Intrepida is developing cancer drugs that engage novel innate immune targets such as BAG3 and IFITM2
Total raised: $9.5M
Investors 2
| Date | Name | Website |
| - | Sofinnova ... | sofinnova.... |
| - | Canaan Par... | canaan.com |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 22.10.2019 | - | $9.5M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 23.10.2019 | Daily fund... | Reibus raised $3.25M; AllWork ... | - | Kristin Ka... | vator.tv/n... |
| 22.10.2019 | Intrepida ... | Intrepida Bio, Inc., a San Die... | USA | - | finsmes.co... |
| 22.10.2019 | Intrepida ... | - | - | - | connect.or... |